Association of cognitive impairment with the interaction between chronic kidney disease and depression: findings from NHANES 20112014
The difference between tirzepatide and compounded tirzepatide The story of FDA approval & legal landscape for tirzepatide and compounded tirzepatide The shortage history Tirzepatide was placed on the FDA drug shortage list in December 2022 due to explosive demand after approval
After adjusting for covariates age, sex, BMI, income, smoking status, alcohol consumption, physical activity, hypertension, type 2 diabetes, dyslipidemia and chronic kidney disease those in the fourth quartile of gamma-glutamyl transferase levels demonstrated the highest risk for SSc, compared with those in the first quartile (adjusted HR = 1.807
A microphysiological cell-culturing system for pharmacokinetic drug exposure and high-resolution imaging of arrays of 3D microtissues
Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group
Scientists are still unraveling why the immune system turns against the body